Privacy Policy
Signals Blog

Contributors

Categories

Right Turn: Thoughts from an engineer on #ILookLikeAnEngineer

by | Aug 28, 2015

. Camila Londono is currently an intern at CCRM, taking a break from working on her PhD at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto under the supervision of Dr. Alison McGuigan. Her research focuses on understanding what...

Update from the Clinic: July

by | Aug 25, 2015

. Welcome to your update from the Clinic for the month of July. Adaptimmune moves a second candidate into the clinic. Ziopharm receives an Orphan Drug Designation for its cutting edge IL-12 technology. Canadian cell therapy company, Hemostemix, keeps moving forward...

Cell Therapy Deal Review: July

by | Aug 18, 2015

. Welcome to your Cell Therapy Deal Review for the month of July. Here at Signals we’ve decided to change the name of this monthly column, to pay consideration to the fact the majority of the technologies discussed here are cell-based. Moving forward, I will continue...

Right Turn: #ILookLikeAnEngineer

by | Aug 7, 2015

. First female scientists were #DistractinglySexy – and hilarious, I might add. (If this means nothing to you, I recommend you read this article for a good recap.) Now their female engineering friends and colleagues are also tackling sexism in STEM – science,...

Regenerative Medicine Deal Review: June

by | Jul 29, 2015

. Welcome to your Regenerative Medicine Deal Review for the month of June. It was an epic month in partnerships that saw multiple collaborations closely tying industry leaders together. Almost all public cell-based immunotherapy companies have formed partnerships with...